- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05040386
Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT
Nurse Coach-Led Early Palliative Care for Older Adults With Chronic Obstructive Pulmonary Disease and Their Care Partners: The Project EPIC Pilot Randomized Controlled Trial
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in older Americans. COPD increases in frequency with age, and older adults with COPD often have significant unmet geriatrics-palliative care needs that results in reduced quality of life, high healthcare utilization, and care at the end of life that does not align with the values and wishes of patients and their care partners. Older adults with COPD could benefit from proactive geriatrics-palliative care before the end of life. However, no geriatrics-palliative care interventions have been systematically developed and tested in community-dwelling older adults with COPD and their care partners. As the number of older adults with COPD increases to levels unmatched by current palliative care workforce trends, innovative strategies are desperately needed to improve the delivery of geriatrics-palliative care in COPD before the end of life.
Project EPIC (Empowering People to Independence in COPD) is a multiphase study to refine and pilot test the EPIC telephonic nurse coaching intervention in older adults with COPD and their care partners. EPIC is informed by the ENABLE (Educate, Nurture, Advise Before Life Ends) early palliative care intervention that improved quality of life and mood for patients with advanced cancer and has been iteratively refined over decades and rigorous randomized controlled trial testing. In the intervention, palliative care-trained nurse coaches deliver the Charting Your Course Curriculum over the phone to patients (six sessions) and their care partners (four sessions), with activities and monthly telephone follow-up following a manualized curriculum. We conducted a formative evaluation in a diverse and multidisciplinary group of stakeholders to refine ENABLE for patients with COPD and pilot tested the potential feasibility of the refined intervention, EPIC, in patients and their care partners.
The current study summatively evaluates EPIC through a hybrid effectiveness-implementation pilot randomized controlled trial in dyads of community-dwelling older adults with moderate to very severe COPD and their care partners randomized to usual care (control) versus EPIC (intervention). The primary outcomes are intervention feasibility and acceptability. Secondary outcomes include Life-Space mobility, quality of life, cognitive impairment, functional status, palliative care uptake, and care partner burden.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Patients
Inclusion criteria (must meet ALL of the following):
- ≥60 years;
- COPD on routinely collected spirometry (FEV1/FVC <0.70 + FEV1<80%);
- Able to speak English;
- At least one of the following:
4a) Severe breathlessness as defined by a documented modified Medical Research Council (mMRC) Dyspnea Scale Score >2 in the medical record or any of the following levels of severe breathlessness by medical review: breathless after walking about 100 yards, breathless after a walking few minutes on level ground, or too breathless to leave the house or when dressing); OR, 4b) ≥1 hospitalization in the year prior but >30 days from enrollment; OR, 4c) On supplemental oxygen (exertional or continuous).
Exclusion criteria (can be excluded for ANY of the following):
- No access to a dedicated telephone service;
- Recent hospitalization for any reason or exacerbation of COPD in the past 30 days or ongoing exacerbation symptoms requiring treatment with antibiotics and steroids;
- Treated within the past 60 days for an advanced cancer defined as metastatic and/or recurrent/progressive stage III/IV cancer, including brain, lung, breast, gynecologic, head and neck, gastrointestinal, genitourinary cancer, and hematologic malignancies by self report or chart review;
- Active schizophrenia, major depressive disorder, bipolar disorder, suicidal ideations, or substance abuse by self-report or chart review (Active means currently being treated for schizophrenia, bipolar disorder, or suicidal ideations or having active and untreated major depressive disorder, i.e. not under the care of a clinician or not on medications such as antidepressants or mood stabilizers, or having active and untreated substance abuse, i.e. not on medication or enrolled in a substance abuse program);
- Non-correctable hearing impairment (i.e. hearing impairment despite hearing aids);
- Severe cognitive impairment (score ≤3 points on 6-item Callahan Screener): a) Correctly identify current year (1 point); b) Correctly identify current month (1 point); c) Correctly identify current day (1 point); d) Correctly recall "apple" after 5 minutes (1 point); e) Correctly recall "table" after 5 minutes (1 point); f) Correctly recall "penny" after 5 minutes (1 point).
Care partners
Inclusion criteria (must meet ALL of the following):
- ≥18 years;
- Self-reporting as "an unpaid spouse or care partner, relative, or friend who knows [the patient] well and is involved in their medical care";
- Able to speak English.
Exclusion criteria (can be excluded for ANY of the following):
- No access to a dedicated telephone service;
- Active schizophrenia, major depressive disorder, bipolar disorder, suicidal ideation, or substance abuse by self-report (Active schizophrenia, major depressive disorder, bipolar disorder, suicidal ideation, or substance abuse by self-report or chart review (Active means currently being treated for schizophrenia, bipolar disorder, or suicidal ideations or having active and untreated major depressive disorder, i.e. not under the care of a clinician or not on medications such as antidepressants or mood stabilizers, or having active and untreated substance abuse, i.e. not on medication or enrolled in a substance abuse program);
- Non-correctable hearing impairment (i.e. hearing impairment despite hearing aids);
- Severe cognitive impairment (score ≤3 points on a 6-item Callahan screener): a) Correctly identify current year (1 point); b) Correctly identify current month (1 point); c) Correctly identify current day (1 point); d) Correctly recall "apple" after 5 minutes (1 point); e) Correctly recall "table" after 5 minutes (1 point); f) Correctly recall "penny" after 5 minutes (1 point)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Usual Care
Patient participants randomized to this arm will receive the standard of care for COPD.
Caregiver participants, if available, will be randomized to the same study arm as the patient participant.
|
Participants randomized to this arm receive standard of care for COPD.
This includes routine clinic visits with their clinician, medications, inhalers, vaccinations, tobacco cessation counseling, illness education, cardiopulmonary rehabilitation, specialist referrals, and other COPD therapies deemed appropriate by their clinician.
Caregiver participants are randomized to the same study arm as the patient participant.
|
|
Experimental: Intervention (EPIC)
Participants randomized to this arm will receive the experimental treatment for COPD (i.e.
EPIC).
Caregiver participants, if available, will be randomized to the same study arm as the patient participant.
|
EPIC (Empower People to Independence in COPD) is a telephonic nurse coach-led palliative care intervention informed by the ENABLE (Educate, Nurture, Advise, Before Life Ends) model for early palliative care, a rigorously tested multicomponent early palliative care model that improved quality of life and emotional symptoms in patients with advanced cancer.
The PI adapted and refined ENABLE for COPD and older adults.
EPIC includes weekly (6 for patients and 4 for caregivers) telephone-based, nurse coach-led sessions aided by a manualized curriculum (Charting Your Course), followed by three once-monthly follow up sessions.
Participants also complete activities on solving problems and making difficult decisions, complete an Advance Directive, and attend a supportive care clinic visit.
Caregiver participants are randomized to the same study arm as the patient participant and receive the caregiver-focused EPIC intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention Feasibility
Time Frame: 6 months
|
In participants randomized to the intervention arm, we will measure the mean (SD) number of core EPIC patient and caregiver telephonic nurse coaching sessions out of a possible 10 and 8 sessions completed, respectively.
|
6 months
|
|
Survey Feasibility
Time Frame: 6 months
|
Survey completion rates will be measured and presented as the count of patient and caregiver participants who completed 100% of all available survey sets across the study.
|
6 months
|
|
Intervention Acceptability Score
Time Frame: 6 months
|
Mean (SD) score on a scale of 1 being very poor and 10 being excellent for the EPIC intervention as rated by patient and caregiver participants randomized to the intervention group.
|
6 months
|
|
Count of Acceptability Qualitative Interviews
Time Frame: 6 months
|
Count of patient and caregiver participants completing the follow-up semi-structured, in-depth interviews.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
UAB Life Space Assessment
Time Frame: 6 months
|
The UAB Life Space Assessment is a 15-item measure of Life-Space mobility, or the frequency, distance, and independence of movement in the 4 weeks prior to administration.
Scores range from 0 (lowest) to 120 (best), and lower scores are associated with more restricted Life-Space mobility.
A threshold score of >=60 is used to identify restricted Life-Space mobility, which is a marker of social isolation, frailty, and predictor of healthcare utilization in older adults.
MCID=5 points with an alpha=0.80.
|
6 months
|
|
Chronic Respiratory Questionnaire (CRQ)
Time Frame: 6 months
|
The Chronic Respiratory Questionnaire (CRQ) is a 20-item measure of quality of life along 4 domains: CRQ dyspnea, CRQ fatigue, CRQ mastery, and CRQ emotional function.
Each domain score ranges from 1 (most severe impairment) to 7 (no impairment).
Higher scores are better on each domain, with MCID of 0.5 points and an alpha=0.70.
The CRQ Dyspnea Domain has a range of 1 to 7, with higher scores associated with a better outcome.
The CRQ Fatigue Domain has a range of 1 to 7, with higher scores associated with better outcome.
The CRQ Mastery Domain has a range of 1 to 7, with higher scores associated with better outcome.
The CRQ Emotional Function Domain has a range of 1 to 7, with higher scores associated with better outcome.
|
6 months
|
|
PROMIS Global Health 10
Time Frame: 6 months
|
The PROMIS Global Health 10 is a 10-item measure of quality of life along 2 domains: physical and mental health.
There are 9 questions rated on a 5-point Likert-scale, and the 10th question rates pain on a scale of 0 to 10. Raw scores are then converted to standardized t-scores ranging from 0 to 100, with lower scores associated with worse quality of life.
PROMIS Global Health Physical Health Domain has a range of 0 to 100, with lower scores associated with worse quality of life.
The PROMIS Global Health Mental Health Domain has a range of 0 to 100, with lower scores associated with worse quality of life.
|
6 months
|
|
Montgomery Borgatta Caregiver Burden
Time Frame: 6 months
|
14-item measure of caregiver burden along 3 domains: objective burden (alpha=0.87-0.90;
Range 6 to 30), subjective stress burden (alpha=0.81-0.88;
Range 4 to 20), and subjective demand burden (alpha =0.68-0.82;
Range 4 to 20).
Higher scores are associated with worse outcome on each domain.
|
6 months
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 6 months
|
14-item measure of emotional symptoms with a 7-item anxiety subscale and a 7-item depression subscale.
Each question has a 4-point Likert scale, and scores from 0-21 per subscale, with higher scores associated with more severe anxiety and depressive symptoms.
A subscale score >=8 on each subscale is the accepted threshold for clinically-elevated anxiety or depressive symptoms.
The minimal clinically important difference is 1.5 points on each subscale with an alpha=0.82-0.83.
|
6 months
|
|
Modified Telephone Interview for Cognitive Status (mTICS)
Time Frame: 6 months
|
14-item measure of cognitive impairment, which has been validated in COPD.
Scores range from 0-50 with higher scores associated with more cognitive impairment.
Validated over telephone (alpha=0.80).
|
6 months
|
|
Katz Index of Activities of Daily Living
Time Frame: 6 months
|
6-item measure of independence in activities.
Range 0-6.
Higher scores associated with more independence; MCID=0.47.
|
6 months
|
|
Lawton Instrumental Activities of Daily Living
Time Frame: 6 months
|
8-item measure of function in independent living, with an MCID=0.47.
Scores range from 1 to 8, with higher scores associated with higher functioning.
alpha=0.85
|
6 months
|
|
Advance Directive Completion
Time Frame: 6 months
|
Rates of patient participant Advance Directive completion.
|
6 months
|
|
De Jon Gierveld Loneliness Scale
Time Frame: 6 months
|
A 6-item measure of loneliness with higher scores associated with more loneliness, range 0 (least lonely) to 6 (most lonely).
Alpha=0.88.
|
6 months
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300007901
- K76AG064327 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, Geneva; Cantonal Hospital St. Gallen, SwitzerlandNot yet recruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
-
China-Japan Friendship HospitalNot yet recruiting
Clinical Trials on Usual Care
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis | FatigueGermany
-
Charite University, Berlin, GermanyMammazentrum Hamburg am Krankenhaus Jerusalem, Germany; Dorit und Alexander...Completed
-
European Institute for Evidence Based Osteopathic...Unknown
-
Suzanna ZickUniversity of MichiganTerminatedQuality of Life | Fatigue | Lupus Erythematosus, Systemic | Sleep | Pain, ChronicUnited States
-
Centers for Disease Control and PreventionCompleted
-
University Hospital, MontpellierCompletedOsteoarthritis | Mindfulness | MBSRFrance
-
Gachon University Gil Oriental Medical HospitalKorea Health Industry Development InstituteCompletedKnee Replacement | AcupunctureKorea, Republic of
-
Mayo ClinicCompleted
-
Parc de Salut MarCompleted
-
The Miriam HospitalNational Institute on Aging (NIA)CompletedHeart FailureUnited States